Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
News and Events

Featured Stories

Hot information:
Top 10 Global CDMO Enterprises| Top 10 Global Clinical Research Organizations in 2021| The Meaning of IND, NDA and ANDA
Sep 01,2015
Scientists have discovered a protein that May Open Door to New Therapies for Infection and Cancer
    Another good news about fighting against cancer.  Scientists at Florida State University say they have taken a critical step forward in the fight against cancer with a discovery that could open up the door for new research and treatment options.     Fanxiu Zhu, Ph.D., the FSU Margaret and Mary Pfeiffer Endowed Professor for Cancer Research, andRead more
More
Scientists have discovered a protein that May Open Door to New Therapies for Infection and Cancer
Aug 31,2015
Blood Test May Help Predict Breast Cancer Relapse
    A simple blood test may in future provide breast cancer patients with an early warning of the disease returning after chemotherapy and surgery.  Conducted repeatedly, a blood test capable of profiling circulating tumor DNA can track genetic changes that occur over time, picking up signs that a treated cancer—in this case, breast cancer—is about toRead more
More
Blood Test May Help Predict Breast Cancer Relapse
Aug 31,2015
Gene with Steady Networks Equal Longer Life Spans
    People are willing to live longer. How do human expand their longer life spans.  Age-defying species—the giant red sea urchin, the painted turtle, the naked mole rat—may begin teaching us how to extend our own lives. All these species stand out because they exhibit negligible senescence, the ability to grow older without suffering functional declinesRead more
More
Aug 31,2015
When cancer makes its way to the brain
Only half of brain cancers actually start in the brain. The rest—as in the case of former President Jimmy Carter—are metastatic tumors from cancer that originated elsewhere in the body.  Dr. Brad Zacharia, director of neuro-oncology and skull-base surgery at Penn State Hershey Medical Center, said between 15 and 30 percent of patients who haveRead more
More
When cancer makes its way to the brain
Aug 28,2015
Sequenom Enters Collaboration with UC San Diego Moores Cancer Center on New Liquid Biopsy Assay
    Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced that it has entered into a clinical research collaboration with the University of California, San Diego Moores Cancer Center.  Moores will explore the utility of Sequenom's new liquid biopsy assay to profile circulating cell-free tumorRead more
More
Aug 28,2015
Regulatory Understudy in the Genome Rehearse for Big Break
    All the genome's a stage, and all the regulatory proteins mere players—or not. Some regulatory proteins just go through the motions, like understudies learning lines they may never perform for real. Such proteins, it now appears, may do more than strut and fret their hour upon the genomic stage, they may also move genomic propsRead more
More
Aug 28,2015
Medivation take on the market for breast cancer patients with BRCA gene mutations
Medivation made a name for itself with Xtandi, the prostate cancer med that's now giving Johnson & Johnson's ($JNJ) Zytiga a run for its money. Now, it wants to challenge other drugmakers in the PARP inhibitor field, too. The company snapped up BioMarin's ($BMRN) cancer-fighting PARP inhibitor in a $570 million deal earlier this week,Read more
More
Medivation take on the market for breast cancer patients with BRCA gene mutations
Aug 27,2015
Syndax Enters Clinical Trial Collaboration in Cancer Immunotherapy with Genentech
    Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing entinostat as a combination therapy in multiple cancer indications, said it will partner with Genentech, a member of the Roche Group, in a combination cancer immunotherapy clinical trial. The value of the collaboration was not disclosed.      "This collaboration expands our emerging immuno-oncology program into an importantRead more
More
Aug 27,2015
Scientists Discover Electrical Control of Cancer Cell Growth
    The molecular switches regulating human cell growth do a great job of replacing cells that die during the course of a lifetime. But when they misfire, life-threatening cancers can occur.  Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control theRead more
More
Scientists Discover Electrical Control of Cancer Cell Growth
Aug 26,2015
Know More About the Bacterial Biofilm
    We often think of bacteria as a group of rapidly proliferating, free-living cells that don't typically unite toward a common purpose. However, this couldn't be further from reality, as microbial existence is much more complex than many may envision. For instance, a number of bacterial species often band together into a collection of cells heldRead more
More